{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "UCH-L1",
        "Protein_Change": {
          "ref": "D",
          "alt": "K",
          "position": "30"
        },
        "variant_string_id": "UCH-L1 D30K"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Parkinson's disease (PD) is a neurodegenerative disorder characterized by the progressive loss of dopaminergic neurons in the substantia nigra pars compacta. Several proteins, including UCH-L1 and a-synuclein, have been implicated in familial PD.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism involving UCH-L1 and a-synuclein mutations affecting protein secretion pathways."
        },
        {
          "step_name": "Step 2: Evaluate assay applicability",
          "extracted_paper_info": "Secretion assays were used to study the functional impact of UCH-L1 mutations on protein secretion.",
          "judgment": "Yes",
          "reasoning": "The assays are relevant for studying the functional impact of mutations in a disease-related pathway."
        },
        {
          "step_name": "Step 3a: Check basic controls and replicates",
          "extracted_paper_info": "The paper does not explicitly describe the use of wild-type or negative controls, nor does it mention multiple replicates.",
          "judgment": "No",
          "reasoning": "Basic controls and replicates are insufficiently described."
        },
        {
          "step_name": "Step 3b: Check accepted/validated assay",
          "extracted_paper_info": "The assay is a standard approach for studying protein secretion in neurodegenerative diseases.",
          "judgment": "Yes",
          "reasoning": "The assay is broadly accepted in the field."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "No statistical analyses or OddsPath calculations were provided for this variant.",
          "judgment": "Supporting",
          "reasoning": "The functional impact is clear but lacks detailed statistical support."
        }
      ],
      "final_evidence_strength": "PS3_supporting"
    },
    {
      "variant_id": {
        "Gene": "UCH-L1",
        "Protein_Change": {
          "ref": "C",
          "alt": "S",
          "position": "90"
        },
        "variant_string_id": "UCH-L1 C90S"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Parkinson's disease (PD) is a neurodegenerative disorder characterized by the progressive loss of dopaminergic neurons in the substantia nigra pars compacta. Several proteins, including UCH-L1 and a-synuclein, have been implicated in familial PD.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism involving UCH-L1 and a-synuclein mutations affecting protein secretion pathways."
        },
        {
          "step_name": "Step 2: Evaluate assay applicability",
          "extracted_paper_info": "Secretion assays were used to study the functional impact of UCH-L1 mutations on protein secretion.",
          "judgment": "Yes",
          "reasoning": "The assays are relevant for studying the functional impact of mutations in a disease-related pathway."
        },
        {
          "step_name": "Step 3a: Check basic controls and replicates",
          "extracted_paper_info": "The paper does not explicitly describe the use of wild-type or negative controls, nor does it mention multiple replicates.",
          "judgment": "No",
          "reasoning": "Basic controls and replicates are insufficiently described."
        },
        {
          "step_name": "Step 3b: Check accepted/validated assay",
          "extracted_paper_info": "The assay is a standard approach for studying protein secretion in neurodegenerative diseases.",
          "judgment": "Yes",
          "reasoning": "The assay is broadly accepted in the field."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "No statistical analyses or OddsPath calculations were provided for this variant.",
          "judgment": "Supporting",
          "reasoning": "The functional impact is clear but lacks detailed statistical support."
        }
      ],
      "final_evidence_strength": "PS3_supporting"
    },
    {
      "variant_id": {
        "Gene": "UCH-L1",
        "Protein_Change": {
          "ref": "I",
          "alt": "M",
          "position": "93"
        },
        "variant_string_id": "UCH-L1 I93M"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Parkinson's disease (PD) is a neurodegenerative disorder characterized by the progressive loss of dopaminergic neurons in the substantia nigra pars compacta. Several proteins, including UCH-L1 and a-synuclein, have been implicated in familial PD.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism involving UCH-L1 and a-synuclein mutations affecting protein secretion pathways."
        },
        {
          "step_name": "Step 2: Evaluate assay applicability",
          "extracted_paper_info": "Secretion assays were used to study the functional impact of UCH-L1 mutations on protein secretion.",
          "judgment": "Yes",
          "reasoning": "The assays are relevant for studying the functional impact of mutations in a disease-related pathway."
        },
        {
          "step_name": "Step 3a: Check basic controls and replicates",
          "extracted_paper_info": "The paper does not explicitly describe the use of wild-type or negative controls, nor does it mention multiple replicates.",
          "judgment": "No",
          "reasoning": "Basic controls and replicates are insufficiently described."
        },
        {
          "step_name": "Step 3b: Check accepted/validated assay",
          "extracted_paper_info": "The assay is a standard approach for studying protein secretion in neurodegenerative diseases.",
          "judgment": "Yes",
          "reasoning": "The assay is broadly accepted in the field."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "No statistical analyses or OddsPath calculations were provided for this variant.",
          "judgment": "Supporting",
          "reasoning": "The functional impact is clear but lacks detailed statistical support."
        }
      ],
      "final_evidence_strength": "PS3_supporting"
    },
    {
      "variant_id": {
        "Gene": "a-synuclein",
        "Protein_Change": {
          "ref": "wild-type",
          "alt": "mutant",
          "position": "N/A"
        },
        "variant_string_id": "a-synuclein mutants"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Parkinson's disease (PD) is a neurodegenerative disorder characterized by the progressive loss of dopaminergic neurons in the substantia nigra pars compacta. Several proteins, including UCH-L1 and a-synuclein, have been implicated in familial PD.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism involving UCH-L1 and a-synuclein mutations affecting protein secretion pathways."
        },
        {
          "step_name": "Step 2: Evaluate assay applicability",
          "extracted_paper_info": "Secretion assays were used to study the functional impact of UCH-L1 mutations on protein secretion.",
          "judgment": "Yes",
          "reasoning": "The assays are relevant for studying the functional impact of mutations in a disease-related pathway."
        },
        {
          "step_name": "Step 3a: Check basic controls and replicates",
          "extracted_paper_info": "The paper does not explicitly describe the use of wild-type or negative controls, nor does it mention multiple replicates.",
          "judgment": "No",
          "reasoning": "Basic controls and replicates are insufficiently described."
        },
        {
          "step_name": "Step 3b: Check accepted/validated assay",
          "extracted_paper_info": "The assay is a standard approach for studying protein secretion in neurodegenerative diseases.",
          "judgment": "Yes",
          "reasoning": "The assay is broadly accepted in the field."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "No statistical analyses or OddsPath calculations were provided for this variant.",
          "judgment": "Supporting",
          "reasoning": "The functional impact is clear but lacks detailed statistical support."
        }
      ],
      "final_evidence_strength": "PS3_supporting"
    }
  ]
}